These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. Aaltonen LA; Salovaara R; Kristo P; Canzian F; Hemminki A; Peltomäki P; Chadwick RB; Kääriäinen H; Eskelinen M; Järvinen H; Mecklin JP; de la Chapelle A N Engl J Med; 1998 May; 338(21):1481-7. PubMed ID: 9593786 [TBL] [Abstract][Full Text] [Related]
3. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. Wijnen JT; Vasen HF; Khan PM; Zwinderman AH; van der Klift H; Mulder A; Tops C; Møller P; Fodde R N Engl J Med; 1998 Aug; 339(8):511-8. PubMed ID: 9709044 [TBL] [Abstract][Full Text] [Related]
4. Multimodal molecular screening is required to improve the sensitivity of MLH1 and MSH2 mutation analysis. Andermann A; Thiffault I; Wong N; Gordon P; MacNamara E; Chong G; Foulkes W J Clin Oncol; 2002 Mar; 20(6):1705-7. PubMed ID: 11896123 [No Abstract] [Full Text] [Related]
12. Incidence of germline hMLH1 and hMSH2 mutations (HNPCC patients) among newly diagnosed colorectal cancers in a Slovenian population. Ravnik-Glavac M; Potocnik U; Glavac D J Med Genet; 2000 Jul; 37(7):533-6. PubMed ID: 10970186 [No Abstract] [Full Text] [Related]
13. [Germline mutation analysis in hMLH 1 and hMSH 2 genes in hereditary nonpolyposis colorectal cancer and colorectal cancer patients with familial history]. Wang Y; Friedl W; Propping P Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Dec; 15(6):333-6. PubMed ID: 9845760 [TBL] [Abstract][Full Text] [Related]
14. Re: Characterization of hereditary nonpolyposis colorectal cancer families from a population-based series of cases. Evans DG; Wu CL; Walsh S; Hansen I; Verma L; Robinson C; Kingston R; Maher ER J Natl Cancer Inst; 2001 May; 93(9):716-7. PubMed ID: 11333295 [No Abstract] [Full Text] [Related]
15. Conversion of diploidy to haploidy. Yan H; Papadopoulos N; Marra G; Perrera C; Jiricny J; Boland CR; Lynch HT; Chadwick RB; de la Chapelle A; Berg K; Eshleman JR; Yuan W; Markowitz S; Laken SJ; Lengauer C; Kinzler KW; Vogelstein B Nature; 2000 Feb; 403(6771):723-4. PubMed ID: 10693791 [No Abstract] [Full Text] [Related]
16. HNPCC associated with germline mutation in the TGF-beta type II receptor gene. Lu SL; Kawabata M; Imamura T; Akiyama Y; Nomizu T; Miyazono K; Yuasa Y Nat Genet; 1998 May; 19(1):17-8. PubMed ID: 9590282 [No Abstract] [Full Text] [Related]
17. Genetic basis of familial endometrial cancer: is there more to learn? Boyd J J Clin Oncol; 2005 Jul; 23(21):4570-3. PubMed ID: 15837976 [No Abstract] [Full Text] [Related]
18. Genetic testing in hereditary non-polyposis colorectal cancer families with a MSH2, MLH1, or MSH6 mutation. Wagner A; Tops C; Wijnen JT; Zwinderman K; van der Meer C; Kets M; Niermeijer MF; Klijn JG; Tibben A; Vasen HF; Meijers-Heijboer H J Med Genet; 2002 Nov; 39(11):833-7. PubMed ID: 12414824 [No Abstract] [Full Text] [Related]
20. Comparison of selection strategies for genetic testing of patients with hereditary nonpolyposis colorectal carcinoma: effectiveness and cost-effectiveness. Reyes CM; Allen BA; Terdiman JP; Wilson LS Cancer; 2002 Nov; 95(9):1848-56. PubMed ID: 12404277 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]